Arbor Rapha Capital Bioholdings Corp. I financial data

Industry
Blank Checks
Location
333 Earle Ovington Blvd., Suite 900, Uniondale, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 10, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 302 %
Debt-to-equity -120 %

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -292K USD
Nonoperating Income (Expense) 798K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 506K USD
Income Tax Expense (Benefit) 156K USD
Net Income (Loss) Attributable to Parent 350K USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 884K USD
Assets, Current 1.28M USD
Assets 179M USD +44435%
Liabilities, Current 772K USD
Liabilities 11.1M USD +2846%
Retained Earnings (Accumulated Deficit) -9.34M USD
Stockholders' Equity Attributable to Parent -9.34M USD -37812%
Liabilities and Equity 179M USD +44435%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -279K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -279K USD -1215%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 884K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%